A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
Clinical trial NCT04762784 · UNKNOWN
Trial details
- NCT number
- NCT04762784
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2023-02-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.